CLCS — Cell Source Cashflow Statement
0.000.00%
Last trade - 00:00- $16.78m
- $3.13m
Annual cashflow statement for Cell Source, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.48 | -4.56 | -5.47 | -5.17 | -5.32 |
| Non-Cash Items | 1.32 | 1.36 | 1.39 | 0.466 | 0.755 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.57 | 0.423 | 0.701 | 1.56 | 2.22 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -2.59 | -2.77 | -3.38 | -3.14 | -2.35 |
| Financing Cash Flow Items | 0.086 | -0.04 | -0.353 | -0.028 | -0.279 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.6 | 2.99 | 3.23 | 3.27 | 2.15 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.009 | 0.217 | -0.152 | 0.13 | -0.2 |